期刊文献+

孟鲁司特钠片联合糖皮质激素治疗老年支气管哮喘的临床疗效观察 被引量:17

暂未订购
导出
摘要 目的观察孟鲁司特钠片联合雾化吸入糖皮质激素治疗老年支气管哮喘的临床疗效。方法选取老年支气管哮喘患者90例,通过计算机随机分组的方式,将其随机分为实验组(A组)和对照组(B组),每组患者45人。B组患者仅给予常规的综合治疗以及吸入糖皮质激素治疗,而A组患者在B组的基础上口服孟鲁司特钠片联合治疗,治疗12周后观察两组的总体治疗效果、肺功能的改善情况、临床症状缓解所需时间、不良反应例数,并于停药6个月后随访复发情况。结果 A组的治疗有效率为88.89%,B组的治疗有效率为66.67%,A组的肺功能改善情况(FEV1、PEF、FEV1%pred)要显著好于B组(P<0.05),临床症状缓解所需时间短于B组(P<0.05),A组不良反应3例,B组4例,两组无显著差异(P>0.05),A组复发率8.89%,B组复发率26.67%,A组复发率显著低于B组(P<0.05)。结论孟鲁司特钠片联合雾化吸入糖皮质激素治疗老年支气管哮喘临床效果显著,复发率低,不良反应少,值得临床推广。
作者 俞建娇
出处 《海峡药学》 2013年第4期102-103,共2页 Strait Pharmaceutical Journal
  • 相关文献

参考文献10

二级参考文献32

共引文献2697

同被引文献89

  • 1胡岗,杨晓华,陈一凡,徐敏,黄海涛.特布他林联合布地奈德雾化吸入用于COPD治疗效果观察[J].山东医药,2013,53(30):28-29. 被引量:20
  • 2中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗及教育和管理方案)[J].中华内科杂志,2003,42(11):817-822. 被引量:309
  • 3Trifilieff A, Bench A, Hanley M, et al. PPAR-alpha and- gamma but not-delta agonists inhibit airway inflammation in a murine model of asthma:in vitro evidence for an NF- kappaB-independent effect[J]. Br J Pharmacol, 2003,139 (1) :163-171.
  • 4Fitzpatrick S, Joks R, Silverberg JI. Obesity is associated with increased asthma severity and exacerbations, and in- creased serum immunoglobulin E in inner-city adults[J]. Clin Exp Allergy, 2012,42 (5) : 747-759.
  • 5Lee KS, Park SJ, Hwang P H, et al. PPAR-gamma modu- lates allergic inflammation through upregulation of PTEN [J]. FASEB J, 2005,19 (8): I033-i035.
  • 6Sandhu MS,Dimov V,Sandhu AK,et al. The use of the peroxisome proliferator-activated receptors gamma ago- nist rosiglitazone to treat airway hyperreactivity[J]. Ann Allergy Asthma Immunol,2012,109(1) :75-77.
  • 7Seppo TR,Laura CF,Bridget FC, et al. Thiazolidinediones and the risk of asthma exacerbation among patients with diabetes:a cohort study[J]. Allergy Asthma Clin Immu- nol,2014,10(1) :34.
  • 8Richards DB,Bareille P,Lindo EL, et al. Treatment with a peroxisomal proliferator activated receptor gamma ago- nist has a modest effect in the allergen challenge model in asthma:a randomised controlled trial[J]. Respir Med, 2010,104 (5) : 668-674.
  • 9Zhao Y, Huang Y, He J, et al. Rosiglitazone, a peroxisome proliferator-activated receptor-3' agonist, attenuates air- way inflammation by inhibiting the proliferation of effee- tot T cells in a murine model of neutrophilic asthma[-J]. Immunol Lett,2014,157(1/2) :9-15.
  • 10Gamble J, Stevenson M, McClean E, et al. The prevalence of nonadherence in difficult asthma[J]. Am J Respir Crit Care Med,2009,180(9) :817-822.

引证文献17

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部